Technology
Health
Biotechnology

Vanda Pharmaceuticals

$12.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.32 (-2.40%) Today
$0.00 (0.00%) As of 4:08 PM EDT after-hours

Why Robinhood?

You can buy or sell VNDA and other stocks, options, ETFs, and crypto commission-free!

About VNDA

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Read More Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Employees
270
Headquarters
Washington, District of Columbia
Founded
2002
Market Cap
687.99M
Price-Earnings Ratio
33.09
Dividend Yield
0.00
Average Volume
615.32K
High Today
$13.50
Low Today
$12.73
Open Price
$13.29
Volume
641.01K
52 Week High
$33.44
52 Week Low
$12.73

Collections

Technology
Health
Biotechnology
Medical
US
North America

VNDA Earnings

-$0.18
-$0.03
$0.11
$0.26
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 31, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.